How Long Are Puberty Blockers Used? What Medical Sources Say About Duration

Key Takeaways
How long are puberty blockers used? Mayo Clinic says many people take the medicine for a few years, and that everyone is different. The Endocrine Society's 2017 guideline says there may be compelling reasons to start sex hormones before age 16.
Mayo Clinic says that when a person stops taking GnRH (gonadotropin-releasing hormone) analogs, puberty starts again.
The Endocrine Society's 2017 guideline describes this treatment as reversible and grades the evidence behind it as low quality.
Oregon Health & Science University (OHSU) Doernbecher says its clinic typically sees patients every three to four months during treatment.
A 2024 U.S. study of 56 youth found that longer time on the medication was associated with lower bone density scores, which were within the normal range.
The short answer
Puberty blockers are used for different lengths of time. Mayo Clinic says many people take the medicine for a few years, and that everyone is different. The Endocrine Society's 2017 guideline links the next step, sex hormone treatment, to a team's confirmation and informed consent, and says there may be compelling reasons to start before age 16.
You may see this medication called puberty blockers, GnRH analogs, or puberty-pausing medication. All three names refer to the same medication, and this page mostly says "puberty-pausing medication."
At TransHealthHub, we pulled these details from clinical sources. Our subpage on Tanner stages and puberty-pausing medication explains how the start point is set.
What the sources say about length
Source | What it says about timing |
Mayo Clinic | Many people take it for a few years; everyone is different |
Endocrine Society, 2017 guideline | Sex hormones start after a team confirms gender incongruence persists and the adolescent can give informed consent; compelling reasons may exist before age 16 |
Endocrine Society, patient guidance | Age of starting hormones is set through discussion among the patient, family, and healthcare team |
OHSU Doernbecher | Patients typically seen every three to four months during treatment |
What happens when it stops
Mayo Clinic says puberty starts again when a person stops taking GnRH analogs, and that the changes are not permanent because the medicines pause puberty. It adds that some teens move on to hormone therapy afterward.
The Endocrine Society's patient guidance states that puberty-blocking medications are reversible. The society's 2017 guideline uses the same description for GnRH agonist treatment and describes sex hormone treatment as partially irreversible. Later systematic reviews have questioned how certain the evidence on reversibility is.
How the next step is decided
Under the 2017 guideline, sex hormone treatment begins after a multidisciplinary team confirms that gender incongruence persists and the adolescent can give informed consent. The guideline says most adolescents have that capacity by age 16. It also says the age of starting hormones is set through discussion among the young person, family, and care team.
Our guide to how teens are assessed explains the evaluation that informs those decisions.
What research says about time on the medication
A 2024 Journal of the Endocrine Society study at one U.S. academic center measured bone density in 56 transgender youth aged 10.4 to 19.8. Of those, 19 were taking puberty-pausing medication alone, with a median of 10 months on it. Total body bone density scores were slightly below average but still in the normal range. In this cross-sectional study, longer time on the medication was associated with lower scores, an association and not proof of cause. The authors wrote that optimizing physical activity, body mass index, and vitamin D status is important for this population.
A 2021 study of one Glasgow, Scotland pediatric endocrinology service looked at 91 young people referred for puberty-pausing medication between 2011 and 2019. Of the 79 who started, six stopped, after a median of 6 months. It is a records review at a single non-U.S. service with no control group and does not explain why anyone stopped. We cite it only as one descriptive data point.
The study populations are small, and the 2017 guideline rates its own evidence as low quality, so duration questions are best discussed with a young person's clinician.
What U.S. medical societies say
The American Medical Association, American Academy of Pediatrics, American Psychological Association, and the Endocrine Society regard this care as evidence-based and medically necessary, and oppose government interference in these decisions.
The American Medical Association said in April 2021 that decisions about medical care belong within the patient-physician relationship.
Where care is available
The Kaiser Family Foundation's (KFF) policy tracker, updated September 29, 2026, reports that 27 states have enacted laws or policies limiting youth access to this care.
Frequently asked questions
Is there a set age to stop? The 2017 guideline says there may be compelling reasons to start sex hormones before age 16, and links the next step to a team's confirmation and informed consent.
Does puberty resume after stopping? Mayo Clinic says puberty starts again when a person stops taking GnRH analogs.
Who decides how long it lasts? The Endocrine Society's patient guidance says the age of starting hormones is set through discussion among the patient, family, and healthcare team. Families with questions about puberty blockers for a specific young person can raise them with that clinician.
Further Reading and Resources
Mayo Clinic: pubertal blockers
Endocrine Society (2017): clinical practice guideline
Endocrine Society (2022): guidance for children and adolescents
Journal of the Endocrine Society (2024): bone density study
KFF (2026): youth access policy tracker
TransHealthHub: Tanner stages and puberty-pausing medication
This page addresses a health topic and reflects the evidence as of October 2026. It is not medical advice. Decisions about a young person's care belong to that young person, their family, and their clinicians.



Comments